Entoura Anxiety Study

Entoura study of medicinal cannabis on anxiety disorders

COVID-19 has brought about much apprehension amongst the Australian community, with the uncertainty of job stability, health and more. Which is why it’s a more important time than ever to ensure that patients accessing medicinal cannabis for mental health are assured of the research and safety behind treatments.

This study, hosted by Applied Cannabis Research in conjunction with Entoura, will recruit 200+ CA Clinics patients over 18 years of age to explore the effects of CBD-based products on anxiety disorder symptoms. This includes excessive fear and anxiety conditions such as depression, acute stress reaction, sleep disturbance, panic disorder (PD), dysregulation of appetite, PTSD, social anxiety disorder (SAD), and obsessive–compulsive disorder (OCD).

The medicinal cannabis products used will be that of Entoura’s, which is committed to producing high quality products with the belief that mental well-being can only be achieved by establishing and maintaining a balance of essential medicinal nutrients.

Am I suitable for this medicinal cannabis study?

Patients over 18 years-old that are approved for prescription of Entoura products through CA Clinics doctors will be eligible to enrol in the study. For more information please see the detailed Participant Information and Consent Form.

If you are interested in finding out more please contact CA Clinics at 1300 991 477.